Lexapro

   
Google
 
Web NewDrugInformation.com

Lexapro


Drug - Lexapro
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Escitalopram Oxalate
Multiple ingredients are in alphabetical order.

Strength - 20MG
The potency of the active ingredient(s), Escitalopram Oxalate. May repeat for multiple part products.

Applicant - FOREST LABS
The firm name holding legal responsibility for Lexapro. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021323
The FDA assigned number to Lexapro. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Lexapro. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 14, 2002
The date Lexapro was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lexapro. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lexapro is in. Format is RX, OTC, DISCN.

Applicant Full Name - Forest Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Lexapro.

Lexapro